<p>文艺复兴集团有限公司在最近向美国证券交易委员会提交的文件中披露，在第二季度将其在 Hims &amp; Hers Health, Inc. (NYSE:HIMS - 免费报告) 的持股增加了 99.0%。该公司在此期间额外购买了 87,755 股后，持有该公司 176,384 股股票。文艺复兴集团有限公司在最近一个季度末持有的 Hims &amp; Hers Health 的股份约占 0.08%，价值 8,793,000 美元。</p>
<p>获取 <strong>Hims &amp; Hers Health</strong> 的提醒：</p>
<ul>
<li>为什么 Hims &amp; Hers 股票在第三季度业绩喜忧参半后可能值得购买</li>
</ul>
<p>其他一些对冲基金和机构投资者最近也调整了对该公司的持股。Nuveen LLC 在第一季度购买了 Hims &amp; Hers Health 的新股份，价值 58,403,000 美元。CloudAlpha Capital Management Limited Hong Kong 在第一季度购买了 Hims &amp; Hers Health 的新股份，价值 20,580,000 美元。密歇根州退休系统在第二季度将其在 Hims &amp; Hers Health 的持股增加了 84.9%。密歇根州退休系统现在持有该公司 1,379,100 股股票，价值 68,748,000 美元，此前在上个季度额外购买了 633,300 股。Jump Financial LLC 在第一季度将其在 Hims &amp; Hers Health 的持股增加了 633.2%。Jump Financial LLC 现在持有该公司 725,445 股股票，价值 21,437,000 美元，此前在上个季度额外购买了 626,496 股。最后，北方信托公司在第一季度将其在 Hims &amp; Hers Health 的持股增加了 19.5%。北方信托公司现在持有该公司 2,435,512 股股票，价值 71,969,000 美元，此前在上个季度额外购买了 397,310 股。目前，63.52% 的股票由机构投资者持有。</p>
<h2>Hims &amp; Hers Health 股票表现</h2>
<p>HIMS 的股票在周三开盘价为 36.36 美元。该公司的债务与股本比率为 1.67，速动比率为 1.64，流动比率为 1.88。该股票的 50 日移动平均线为 50.12 美元，200 日移动平均线为 51.42 美元。该股票的市值为 82.8 亿美元，市盈率为 67.33，市盈增长比率为 7.08，贝塔系数为 2.20。Hims &amp; Hers Health, Inc. 的一年最低价为 20.02 美元，一年最高价为 72.98 美元。</p>
<ul>
<li>Hims &amp; Hers 的空头头寸接近历史最高水平，是否值得抄底？</li>
</ul>
<p>Hims &amp; Hers Health (NYSE:HIMS - 获取免费报告) 最近于 11 月 3 日星期一公布了季度财报。该公司报告每股收益 (EPS) 为 0.06 美元，低于市场共识预期的 0.09 美元，差额为 0.03 美元。该公司在本季度的收入为 5.9898 亿美元，而分析师预期为 5.7899 亿美元。Hims &amp; Hers Health 的股本回报率为 24.67%，净利润率为 6.05%。该公司的季度收入较去年同期增长了 49.2%。在去年同期，该公司每股收益为 0.32 美元。Hims &amp; Hers Health 已设定 2025 财年的每股收益指导。2025 财年第四季度的指导为每股收益。整体来看，研究分析师预测 Hims &amp; Hers Health, Inc. 本年度将发布 0.29 的每股收益。</p>
<p>Hims &amp; Hers Health 宣布其董事会已于 11 月 17 日星期一批准了一项股票回购计划，授权公司回购 2.5 亿美元的流通股票。该回购授权允许公司通过公开市场购买最多 3% 的股票。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
<h2>Hims &amp; Hers Health 的内部买卖</h2>
<ul>
<li>3 只利用人工智能推动增长的医疗保健股票</li>
</ul>
<p>在 Hims &amp; Hers Health 的其他新闻中，内部人士 Soleil Boughton 于 11 月 10 日星期一出售了 2,637 股该公司的股票。股票以平均价格 42.53 美元出售，总价值为 112,151.61 美元。出售后，内部人士直接持有该公司 155,856 股股票，价值约 6,628,555.68 美元。这代表其持股减少了 1.66%。该交易已在向证券交易委员会提交的文件中披露，可以通过此链接访问。此外，首席财务官 Oluyemi Okupe 于 10 月 17 日星期五出售了 11,592 股 Hims &amp; Hers Health 股票。股票以平均价格 57.13 美元出售，总价值为 662,250.96 美元。交易后，首席财务官持有该公司 70,232 股股票，价值 4,012,354.16 美元。该交易使其持股减少了 14.17%。该出售的披露信息可在证券交易委员会的文件中找到。在过去的九十天里，内部人士出售了价值 31,837,916 美元的 584,209 股公司股票。公司内部人士持有该公司 17.71% 的股份。</p>
<h2>华尔街分析师的看法</h2>
<p>HIMS 最近成为几份分析师报告的主题。Canaccord Genuity Group 在 9 月 12 日星期五的研究报告中重申了对 Hims &amp; Hers Health 股票的 &#34;买入&#34; 评级，并设定了 68.00 美元的目标价。Wall Street Zen 在 11 月 8 日星期六的报告中将 Hims &amp; Hers Health 的评级从 &#34;持有&#34; 下调至 &#34;卖出&#34;。BTIG Research 在 11 月 4 日星期二的研究报告中重新发布了 &#34;买入&#34; 评级，并对 Hims &amp; Hers Health 股票设定了 85.00 美元的目标价。Truist Financial 在 8 月 18 日星期一的研究报告中将 Hims &amp; Hers Health 的目标价从 48.00 美元下调至 37.00 美元，并对该股票设定了 &#34;持有&#34; 评级。最后，Needham &amp; Company LLC 在 8 月 5 日星期二的研究报告中重申了对 Hims &amp; Hers Health 股票的 &#34;持有&#34; 评级。两位股票研究分析师对该股票给予了买入评级，十位分析师给予了持有评级，三位分析师给予了卖出评级。根据 MarketBeat 的数据，该股票的共识评级为 &#34;减持&#34;，共识目标价为 45.27 美元。</p>
<p><strong>阅读我们关于 Hims &amp; Hers Health 的最新报告</strong></p>
<h2>Hims &amp; Hers Health 公司简介</h2>
<p>(免费报告)</p>
<p>Hims &amp; Hers Health, Inc. 运营一个远程医疗咨询平台。它将消费者与医疗专业人士连接起来，使他们能够获得心理健康、性健康、皮肤科和初级护理的医疗服务。该公司成立于 2017 年，总部位于加利福尼亚州旧金山。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票，胜过 Hims &amp; Hers Health</li>
<li>如何找到财报电话会议记录</li>
<li>美敦力股票找到立足点——现在正在获得动能</li>
<li>如何投资保险公司：指南</li>
<li>感恩节餐桌上有什么？每道菜的股票推荐</li>
<li>股息筛选器：如何在购买前评估股息股票</li>
<li>为什么家得宝的痛苦可能是长期投资者的收益</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhJTVM?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhJTVM"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 $1,000 在 Hims &amp; Hers Health 吗？</h2>
<p>在你考虑 Hims &amp; Hers Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已确定五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 Hims &amp; Hers Health 并不在名单上。</p>
<p>虽然 Hims &amp; Hers Health 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

HIMS

<p>Renaissance Group LLC 在第二季度将其在 Hims & Hers Health, Inc. 的持股增加了 99%，额外购买了 87,755 股，总计持有 176,384 股，价值 879 万美元。机构投资者目前持有该股票的 63.52%。Hims & Hers Health 报告第三季度每股收益为 0.06 美元，未达到预期，收入同比增长 49.2%。该公司宣布了一项 2.5 亿美元的股票回购计划，表明其可能被低估。近期还报告了内部人士的销售情况</p>

<p>Renaissance Group LLC lifted its holdings in Hims &amp; Hers Health, Inc. (NYSE:HIMS - Free Report) by 99.0% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 176,384 shares of the company's stock after purchasing an additional 87,755 shares during the period. Renaissance Group LLC owned about 0.08% of Hims &amp; Hers Health worth $8,793,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>文艺复兴集团有限公司在最近向美国证券交易委员会提交的文件中披露，在第二季度将其在 Hims &amp; Hers Health, Inc. (NYSE:HIMS - 免费报告) 的持股增加了 99.0%。该公司在此期间额外购买了 87,755 股后，持有该公司 176,384 股股票。文艺复兴集团有限公司在最近一个季度末持有的 Hims &amp; Hers Health 的股份约占 0.08%，价值 8,793,000 美元。</p>
</div><p>Get <strong>Hims &amp; Hers Health</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Hims &amp; Hers Health</strong> 的提醒：</p>
</div><ul>
<li>Why Hims &amp; Hers Stock May Be a Buy After Mixed Q3 Results</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么 Hims &amp; Hers 股票在第三季度业绩喜忧参半后可能值得购买</li>
</ul>
</div><p>A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Nuveen LLC purchased a new stake in Hims &amp; Hers Health during the first quarter worth $58,403,000. CloudAlpha Capital Management Limited Hong Kong purchased a new stake in shares of Hims &amp; Hers Health during the 1st quarter worth $20,580,000. State of Michigan Retirement System grew its stake in Hims &amp; Hers Health by 84.9% in the second quarter. State of Michigan Retirement System now owns 1,379,100 shares of the company's stock valued at $68,748,000 after purchasing an additional 633,300 shares during the last quarter. Jump Financial LLC raised its holdings in Hims &amp; Hers Health by 633.2% in the first quarter. Jump Financial LLC now owns 725,445 shares of the company's stock worth $21,437,000 after purchasing an additional 626,496 shares in the last quarter. Finally, Northern Trust Corp lifted its position in shares of Hims &amp; Hers Health by 19.5% during the first quarter. Northern Trust Corp now owns 2,435,512 shares of the company's stock valued at $71,969,000 after buying an additional 397,310 shares during the last quarter. 63.52% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他一些对冲基金和机构投资者最近也调整了对该公司的持股。Nuveen LLC 在第一季度购买了 Hims &amp; Hers Health 的新股份，价值 58,403,000 美元。CloudAlpha Capital Management Limited Hong Kong 在第一季度购买了 Hims &amp; Hers Health 的新股份，价值 20,580,000 美元。密歇根州退休系统在第二季度将其在 Hims &amp; Hers Health 的持股增加了 84.9%。密歇根州退休系统现在持有该公司 1,379,100 股股票，价值 68,748,000 美元，此前在上个季度额外购买了 633,300 股。Jump Financial LLC 在第一季度将其在 Hims &amp; Hers Health 的持股增加了 633.2%。Jump Financial LLC 现在持有该公司 725,445 股股票，价值 21,437,000 美元，此前在上个季度额外购买了 626,496 股。最后，北方信托公司在第一季度将其在 Hims &amp; Hers Health 的持股增加了 19.5%。北方信托公司现在持有该公司 2,435,512 股股票，价值 71,969,000 美元，此前在上个季度额外购买了 397,310 股。目前，63.52% 的股票由机构投资者持有。</p>
</div><h2>Hims &amp; Hers Health Stock Performance</h2>
<div class="lb-trans"><h2>Hims &amp; Hers Health 股票表现</h2>
</div><p>Shares of HIMS opened at $36.36 on Wednesday. The company has a debt-to-equity ratio of 1.67, a quick ratio of 1.64 and a current ratio of 1.88. The stock has a 50-day moving average of $50.12 and a two-hundred day moving average of $51.42. The stock has a market cap of $8.28 billion, a P/E ratio of 67.33, a P/E/G ratio of 7.08 and a beta of 2.20. Hims &amp; Hers Health, Inc. has a one year low of $20.02 and a one year high of $72.98.</p>
<div class="lb-trans"><p>HIMS 的股票在周三开盘价为 36.36 美元。该公司的债务与股本比率为 1.67，速动比率为 1.64，流动比率为 1.88。该股票的 50 日移动平均线为 50.12 美元，200 日移动平均线为 51.42 美元。该股票的市值为 82.8 亿美元，市盈率为 67.33，市盈增长比率为 7.08，贝塔系数为 2.20。Hims &amp; Hers Health, Inc. 的一年最低价为 20.02 美元，一年最高价为 72.98 美元。</p>
</div><ul>
<li>Hims &amp; Hers Short Interest Nears All-Time High, Buy The Dip?</li>
</ul>
<div class="lb-trans"><ul>
<li>Hims &amp; Hers 的空头头寸接近历史最高水平，是否值得抄底？</li>
</ul>
</div><p>Hims &amp; Hers Health (NYSE:HIMS - Get Free Report) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.03). The firm had revenue of $598.98 million during the quarter, compared to analysts' expectations of $578.99 million. Hims &amp; Hers Health had a return on equity of 24.67% and a net margin of 6.05%.The company's revenue for the quarter was up 49.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.32 earnings per share. Hims &amp; Hers Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. As a group, research analysts predict that Hims &amp; Hers Health, Inc. will post 0.29 EPS for the current year.</p>
<div class="lb-trans"><p>Hims &amp; Hers Health (NYSE:HIMS - 获取免费报告) 最近于 11 月 3 日星期一公布了季度财报。该公司报告每股收益 (EPS) 为 0.06 美元，低于市场共识预期的 0.09 美元，差额为 0.03 美元。该公司在本季度的收入为 5.9898 亿美元，而分析师预期为 5.7899 亿美元。Hims &amp; Hers Health 的股本回报率为 24.67%，净利润率为 6.05%。该公司的季度收入较去年同期增长了 49.2%。在去年同期，该公司每股收益为 0.32 美元。Hims &amp; Hers Health 已设定 2025 财年的每股收益指导。2025 财年第四季度的指导为每股收益。整体来看，研究分析师预测 Hims &amp; Hers Health, Inc. 本年度将发布 0.29 的每股收益。</p>
</div><p>Hims &amp; Hers Health announced that its board has approved a stock buyback program on Monday, November 17th that authorizes the company to repurchase $250.00 million in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 3% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's management believes its stock is undervalued.</p>
<div class="lb-trans"><p>Hims &amp; Hers Health 宣布其董事会已于 11 月 17 日星期一批准了一项股票回购计划，授权公司回购 2.5 亿美元的流通股票。该回购授权允许公司通过公开市场购买最多 3% 的股票。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
</div><h2>Insider Buying and Selling at Hims &amp; Hers Health</h2>
<div class="lb-trans"><h2>Hims &amp; Hers Health 的内部买卖</h2>
</div><ul>
<li>3 Healthcare Stocks Using AI to Drive Growth</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只利用人工智能推动增长的医疗保健股票</li>
</ul>
</div><p>In other Hims &amp; Hers Health news, insider Soleil Boughton sold 2,637 shares of the company's stock in a transaction on Monday, November 10th. The shares were sold at an average price of $42.53, for a total value of $112,151.61. Following the sale, the insider directly owned 155,856 shares of the company's stock, valued at approximately $6,628,555.68. This represents a 1.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through this link. Also, CFO Oluyemi Okupe sold 11,592 shares of Hims &amp; Hers Health stock in a transaction dated Friday, October 17th. The shares were sold at an average price of $57.13, for a total value of $662,250.96. Following the transaction, the chief financial officer owned 70,232 shares of the company's stock, valued at $4,012,354.16. The trade was a 14.17% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 584,209 shares of company stock worth $31,837,916. Company insiders own 17.71% of the company's stock.</p>
<div class="lb-trans"><p>在 Hims &amp; Hers Health 的其他新闻中，内部人士 Soleil Boughton 于 11 月 10 日星期一出售了 2,637 股该公司的股票。股票以平均价格 42.53 美元出售，总价值为 112,151.61 美元。出售后，内部人士直接持有该公司 155,856 股股票，价值约 6,628,555.68 美元。这代表其持股减少了 1.66%。该交易已在向证券交易委员会提交的文件中披露，可以通过此链接访问。此外，首席财务官 Oluyemi Okupe 于 10 月 17 日星期五出售了 11,592 股 Hims &amp; Hers Health 股票。股票以平均价格 57.13 美元出售，总价值为 662,250.96 美元。交易后，首席财务官持有该公司 70,232 股股票，价值 4,012,354.16 美元。该交易使其持股减少了 14.17%。该出售的披露信息可在证券交易委员会的文件中找到。在过去的九十天里，内部人士出售了价值 31,837,916 美元的 584,209 股公司股票。公司内部人士持有该公司 17.71% 的股份。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师的看法</h2>
</div><p>HIMS has been the subject of several recent analyst reports. Canaccord Genuity Group reiterated a &#34;buy&#34; rating and set a $68.00 price objective on shares of Hims &amp; Hers Health in a research note on Friday, September 12th. Wall Street Zen lowered Hims &amp; Hers Health from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a report on Saturday, November 8th. BTIG Research reissued a &#34;buy&#34; rating and issued a $85.00 price objective on shares of Hims &amp; Hers Health in a research report on Tuesday, November 4th. Truist Financial dropped their target price on Hims &amp; Hers Health from $48.00 to $37.00 and set a &#34;hold&#34; rating on the stock in a research note on Monday, August 18th. Finally, Needham &amp; Company LLC reaffirmed a &#34;hold&#34; rating on shares of Hims &amp; Hers Health in a research report on Tuesday, August 5th. Two equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of &#34;Reduce&#34; and a consensus price target of $45.27.</p>
<div class="lb-trans"><p>HIMS 最近成为几份分析师报告的主题。Canaccord Genuity Group 在 9 月 12 日星期五的研究报告中重申了对 Hims &amp; Hers Health 股票的 &#34;买入&#34; 评级，并设定了 68.00 美元的目标价。Wall Street Zen 在 11 月 8 日星期六的报告中将 Hims &amp; Hers Health 的评级从 &#34;持有&#34; 下调至 &#34;卖出&#34;。BTIG Research 在 11 月 4 日星期二的研究报告中重新发布了 &#34;买入&#34; 评级，并对 Hims &amp; Hers Health 股票设定了 85.00 美元的目标价。Truist Financial 在 8 月 18 日星期一的研究报告中将 Hims &amp; Hers Health 的目标价从 48.00 美元下调至 37.00 美元，并对该股票设定了 &#34;持有&#34; 评级。最后，Needham &amp; Company LLC 在 8 月 5 日星期二的研究报告中重申了对 Hims &amp; Hers Health 股票的 &#34;持有&#34; 评级。两位股票研究分析师对该股票给予了买入评级，十位分析师给予了持有评级，三位分析师给予了卖出评级。根据 MarketBeat 的数据，该股票的共识评级为 &#34;减持&#34;，共识目标价为 45.27 美元。</p>
</div><p><strong>Read Our Latest Report on Hims &amp; Hers Health</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 Hims &amp; Hers Health 的最新报告</strong></p>
</div><h2>Hims &amp; Hers Health Company Profile</h2>
<div class="lb-trans"><h2>Hims &amp; Hers Health 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Hims &amp; Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.</p>
<div class="lb-trans"><p>Hims &amp; Hers Health, Inc. 运营一个远程医疗咨询平台。它将消费者与医疗专业人士连接起来，使他们能够获得心理健康、性健康、皮肤科和初级护理的医疗服务。该公司成立于 2017 年，总部位于加利福尼亚州旧金山。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Hims &amp; Hers Health</li>
<li>Where to Find Earnings Call Transcripts</li>
<li>Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum</li>
<li>How to Invest in Insurance Companies: A Guide</li>
<li>What’s on the Thanksgiving Table? A Stock Pick for Every Course</li>
<li>Dividend Screener: How to Evaluate Dividend Stocks Before Buying</li>
<li>Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过 Hims &amp; Hers Health</li>
<li>如何找到财报电话会议记录</li>
<li>美敦力股票找到立足点——现在正在获得动能</li>
<li>如何投资保险公司：指南</li>
<li>感恩节餐桌上有什么？每道菜的股票推荐</li>
<li>股息筛选器：如何在购买前评估股息股票</li>
<li>为什么家得宝的痛苦可能是长期投资者的收益</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhJTVM" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=HIMS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Hims &amp; Hers Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在 Hims &amp; Hers Health 吗？</h2>
</div><p>Before you consider Hims &amp; Hers Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Hims &amp; Hers Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hims &amp; Hers Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已确定五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 Hims &amp; Hers Health 并不在名单上。</p>
</div><p>While Hims &amp; Hers Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Hims &amp; Hers Health 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Renaissance Group LLC 收购了 Hims & Hers Health, Inc. 的 87,755 股股票 $HIMS